Stem Cell Treatment Effectiveness: 6 Critical Contraindications You Must Never Ignore

This article is written by Lee Jang-ho, CEO of StemmediCare, based on 10 years of clinical experience with stem cell treatment in Gangnam, Seoul. While stem cell therapy is known to be effective in improving various symptoms such as arthritis, spinal diseases, and skin regeneration, it is not safe or effective for all patients. In particular, depending on specific diseases, health conditions, and medication use, the procedure may be contraindicated or could lead to serious complications. This article organizes the contraindications and side effect risks that must be confirmed before receiving stem cell treatment, focusing on specific case examples.

When stem cell treatment is performed during active infection, especially bacterial or viral infection, the infection can rapidly worsen. This is because stem cells have immune regulatory functions that can temporarily suppress normal immune responses. If the procedure is performed during active viral infections such as tuberculosis, pneumonia, urinary tract infections, or even COVID-19, the body's defense system weakens and cannot prevent infection spread.

In a real case, a patient in their 40s received stem cell injections for knee arthritis treatment, and an undiagnosed urinary tract infection rapidly worsened afterward, progressing to sepsis risk. This was because the immune regulatory effects of stem cells weakened infection defense. Therefore, the procedure is only possible at least 4 weeks after completing infection treatment.

•Infection spread rate increases more than 2x when procedure is performed during active infection

•Medical consultation is essential even while taking antibiotics or antivirals

•Even low-grade fever or mild symptoms must be disclosed in advance

Stem cells are cells with high regenerative capacity, and while they excel at repairing normal cells, they may also stimulate growth of malignant tumor cells. In particular, they are absolutely contraindicated in patients currently undergoing cancer treatment or with a history of cancer diagnosis within the past 5 years. This is because the angiogenic effect (new blood vessel formation) of stem cells could promote nutrient supply to cancer cells.

There is a case where a lung cancer survivor in their 50s indiscriminately received stem cell treatment for spinal pain and experienced cancer recurrence 1 year later. While stem cells may not be the direct cause, they likely provided an environment that increased recurrence risk. Consultation is only possible at least 5 years after cancer diagnosis and after confirming complete remission status.

•Advanced cancer (Stage 3~4): Absolutely contraindicated

•Cancer history within 5 years: Oncologist approval required

•During chemotherapy: Consider procedure at least 6 months after completion

While stem cell treatment is injected into a local area, inflammation and blood clot formation can occur during the injection process. Particularly in patients with heart valve disease or aortic aneurysm, such inflammation carries the risk of serious cardiovascular events (myocardial infarction, stroke). Blood coagulation mechanisms in patients with existing heart disease are unstable, and even minor inflammation from stem cell injection can be fatal.

There is a case where a patient in their 60s, 3 years after artificial valve implantation, underwent stem cell treatment for knee arthritis but developed pulmonary embolism due to blood clotting 1 week after the procedure, requiring emergency hospitalization. Both medical staff and patient failed to sufficiently recognize this risk. Patients with heart disease must obtain written consent from a cardiologist.

•Artificial valve patients: Cardiologist evaluation required

•During arrhythmia treatment: Anticoagulant medication status verification essential

•Aortic aneurysm 5cm or larger: Absolutely contraindicated

Patients with active autoimmune diseases such as rheumatoid arthritis, lupus, and ankylosing spondylitis may experience unexpected immune system escalation due to stem cell treatment. The immune regulatory effects of stem cells can act imbalancedly, potentially promoting autoantibody production. This is particularly risky for patients taking TNF-α inhibitors or biological agents.

There was a case where a woman in her 40s underwent stem cell treatment for rheumatoid arthritis remission, and 2 weeks after the procedure, inflammation markers (CRP, ESR) increased 3 times higher than before, with systemic skin rashes and joint swelling worsening. This likely indicates that stem cells stimulated an autoantibody response. Patients with autoimmune disease can only undergo the procedure in a state of complete disease remission, and prior consultation with a rheumatologist is essential.

•Current active symptoms: Minimum 3 months required after completing treatment

•Currently taking biological agents: Immunological evaluation required

•History of macrophage activation syndrome: Contraindicated

Patients with hemophilia, thrombocytopenia, or those on long-term anticoagulants such as warfarin or dabigatran may experience excessive bleeding, hematoma formation, and nerve compression at the injection site from stem cell injection. When a stem cell injection needle damages microscopic blood vessels, normal individuals naturally achieve hemostasis, but patients with coagulation disorders may experience continuous bleeding and hematoma enlargement.

There is a case where a man in his 70s taking warfarin for atrial fibrillation underwent stem cell treatment for knee arthritis but developed a persistent hematoma in the knee over 3 days after the procedure, causing elevated intra-joint pressure and leg numbness due to nerve compression. Emergency aspiration was necessary. Patients taking anticoagulants must discontinue medication at least 5-7 days prior and undergo coagulation testing, and the procedure cannot be performed without explicit physician approval.

•Cases where anticoagulants cannot be discontinued: Absolutely contraindicated

•INR (International Normalized Ratio) 3.0 or higher: Procedure contraindicated

•Platelets 50,000 or lower: Contraindicated

Because sufficient long-term safety data on stem cell treatment for fetuses and newborns is lacking, pregnant or breastfeeding women must absolutely not undergo the procedure. The possibility that stem cell-derived substances may cross the placenta or be secreted into breast milk cannot be completely ruled out. Although no direct adverse cases have been reported to date, exposing pregnant women or nursing mothers to unverified risks violates medical ethics.

There was a case where a pregnant woman in her 30s underwent stem cell treatment for arthritis, after which fetal growth retardation was discovered, causing intense stress due to premature labor risk. Although direct causal relationship with the procedure was not proven, a preventable risk was taken. If pregnancy is planned, the procedure is only possible at least 3 months before; if currently breastfeeding, the procedure is only possible at least 1 month after complete cessation.

•Currently pregnant: Absolutely contraindicated

•Currently breastfeeding: Minimum 4 weeks required after cessation

•Women planning pregnancy: Consultation 3 months before procedure

Accurate identification of the above 6 contraindications requires thorough medical evaluation before the procedure. StemmediCare mandatorily implements the following step-by-step examinations:

Initial Consultation: Detailed history intake of entire medical history, medication history, and infection status

Blood Tests: Infection markers (WBC, CRP), coagulation tests (PT, INR), tumor marker screening

Imaging Diagnosis: CT/MRI screening for cancer and heart disease

Specialist Evaluation: Consultation with cardiology, oncology, and immunology specialists as needed

Final Suitability Determination: Judgment on procedure eligibility/conditional eligibility/contraindication

Medical institutions that promise "rapid procedure" without this process cannot be trusted.

Q1: Can I receive stem cell treatment if I have diabetes?
A: Diabetes itself is not a contraindication. However, in cases where blood sugar control is poor (fasting blood glucose above 200), diabetic neuropathy is present, or infection risk is high, the procedure should be performed only after thorough blood sugar management. Since infection risk is particularly elevated, prior consultation is essential.

Q2: Can I undergo the procedure while taking blood pressure medication?
A: Most blood pressure medications are unrelated to the procedure. However, if blood pressure is not controlled below 180/110, it is better to postpone the procedure. There is an increased risk of blood vessel damage. The principle is to stabilize blood pressure with medication before proceeding with the procedure.

Q3: Can I receive stem cell treatment after vaccination?
A: Common vaccines (influenza, pneumococcal) are not problematic. However, in the case of mRNA vaccines (COVID-19), immune response persists for 2 weeks after vaccination, so it is recommended to perform the procedure at least 3 weeks later. It is good to consult with medical staff in advance to evaluate your personal immune status.

Q4: Can people carrying hepatitis virus (Hepatitis B) undergo the procedure?
A: If you are a Hepatitis B antigen carrier (HBsAg positive), the procedure is possible, but should be avoided when viral replication is active (HBV DNA > 10^5). It is safest to perform the procedure only in a virus-suppressed state after liver specialist evaluation.

The 6 contraindications introduced in this article are not merely 'recommendations' but 'standards that must be followed'. According to StemmediCare clinical records, the complication rate among patients who ignored contraindications and forced the procedure is over 40%. This is more than 8 times higher than the complication rate (2-5%) in patients who underwent appropriate testing. In particular, complications in patients with active infection status or cancer history history progress beyond simple pain to hospitalization and emergency treatment.

Therefore, while stem cell treatment has significant effects, it can only be safely received through thorough pre-examination and verification of contraindications. Skipping examinations for cost reduction or time savings is absolutely forbidden.

Stem cell treatment is an effective therapeutic method that can improve various symptoms such as arthritis, spinal disease, and skin regeneration. However, it is not suitable for all patients, and in particular, it must absolutely not be performed in cases of active infection, cancer history, heart disease, autoimmune disease, coagulation disorders, or pregnancy/breastfeeding status. Overlooking these contraindications increases complication risk by over 40%.

StemmediCare mandatorily conducts a pre-evaluation process that thoroughly reviews these contraindications. Through blood tests, imaging diagnosis, and specialist consultation, we accurately determine your procedure eligibility. The most certain way to maximize stem cell treatment effects while minimizing complications is not rapid treatment, but accurate pre-examination.

If you would like consultation on stem cell treatment contraindications and safe procedures, contact StemmediCare in Gangnam, Seoul. The medical team led by CEO Lee Jang-ho provides personalized evaluation and consultation based on 10 years of clinical experience. For consultation, contact 02-547-1030 or stemmedicare@stemmedicare.com.

---

📍 Learn More About StemmediCare

•🌐 Homepage: http://www.stemmedicare.com/en/